TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
CRBU

Caribou Biosciences Inc

Healthcare · Biotechnology

1.30$ +2.4% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement CRBU
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
408.3% 278.5% 10.3% 26.3% 10.2% 39.3% 32.7%
100.0% -178.5% 89.7% 73.7% 89.8% 60.7% 67.3%
408.3% 278.5% 544.4% 593.7% 325.1% 1,302.3% 980.7%
284.3% 113.7% 253.4% 274.5% 111.6% 464.8% 339.8%
692.7% 113.7% 787.6% 841.9% 426.4% 1,727.9% 1,287.8%
-592.7% -292.2% -697.8% -768.2% -336.6% -1,667.2% -1,220.5%
0.1% 0.2% 0.1% 61.6% – – –
-535.0% -292.3% -693.9% -717.3% -295.5% -1,492.0% -1,332.3%
-130.2% -14.7% 3.3% 0.5% 0.6% -0.1% -4.9%
-404.8% -277.6% -697.3% -717.8% -296.1% -1,491.9% -1,327.4%
-522.0% -284.8% -683.6% -691.0% -285.3% -1,452.7% -1,299.7%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?